Economy Yahoo Finance 1h ago

Stock Market Today, Feb. 18: ImmunityBio Soars After EU Approves ANKTIVA for Bladder Cancer

Market Intelligence Analysis

AI-Powered
Why This Matters

ImmunityBio's stock is experiencing a surge after the EU approved ANKTIVA for bladder cancer treatment, but investors are also concerned about the company's performance since its IPO and recent legal issues.

Market Impact

Market impact analysis based on bullish sentiment with 70% confidence.

Sentiment
Bullish
AI Confidence
70%
Time Horizon
Short Term

Article Context

Note: This is a brief excerpt for context. Click below to read the full article on the original source.

On Feb. 18, 2026, investors weighed ImmunityBio’s EU bladder cancer win against its long slide since IPO and fresh legal scrutiny.

Continue Reading
Full article on Yahoo Finance
Read Full Article

Related Articles

Economy 23m ago

Morgan Stanley's Wilson: We're In New Economic, Earnings Cycle

Morgan Stanley's Mike Wilson predicts a new economic and earnings cycle, citing broadening of the …
Economy 38m ago

Analysts revamp Palantir stock rating

Analysts have revised their rating on Palantir (PLTR) stock, contributing to a 5% increase in …
Economy 53m ago

Wall Street ends higher, lifted by Nvidia and other AI stocks

The US stock market ended higher on Wednesday, driven by gains in AI stocks such …
Economy 28m ago

Dow Jones 101: How many stocks are in the Dow in 2026?

The article provides a historical overview of the Dow Jones Industrial Average, highlighting its origins …
Economy 56m ago

Stock market today: Dow, S&P 500, Nasdaq futures steady with Wall Street …

The stock market is expected to remain steady, with Wall Street on a win streak …
Economy 1h ago

Cathie Wood buys $14 million of megacap AI stocks

Cathie Wood, a prominent tech investor, has invested $14 million in megacap AI stocks Broadcom …
Original article published by Yahoo Finance on February 19, 2026.
Analysis and insights provided by AnalystMarkets AI.